What is the optimal patient selection for combined androgen ablative and radiation therapy?: The role of combined modality staging

Hematology/Oncology Clinics of North America

Volumn 10, Issue 3, 1996, Pages 643-651

  D'Amico, A V ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN;

CANCER HORMONE THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; DRUG EFFICACY; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TREATMENT OUTCOME;

EID: 0030008352     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70358-0     Document Type: Article

References (13)

1. D.R. Cox Regression models and life tables Journal of the Royal Statistics Society B34 1972 1
2. E.D. Crawford M.A. Eisenberger D.G. McLeod A controlled trial of leuprolide with and without flutamide in prostatic carcinoma N Engl J Med 321 1989 419
3. A.V. D'Amico R. Whittington S.B. Malkowicz A multivariate analysis of clinical and pathological factors which predict for prostate-specific antigen failure after radical prostatectomy after prostate cancer J Urol 154 1995 131
4. A.V. D'Amico R. Whittington S.B. Malkowicz A multivariable analysis of clinical factors prediciting for pathological features associated with local failure after radical prostatectomy for prostate cancer Int J Radiat Oncol Biol Phys 30 1994 293
5. M.A. Eisenberger P.J. O'Dwyer M.A. Friedman Gonadotropin hormone releasing hormone analogues: A new therapeutic approach for prostatic cancer J Clin Oncol 4 1986 414
6. J.I. Epstein G. Pizov P.C. Walsh Correlation of pathologic findings with progression after radical retropublic prostatectomy Cancer 71 1993 3582
7. J.D. Forman M.D. Wharman D.J. Lee Definitive radiotherapy following prostatectomy: Results and complications Int J Radiat Oncol Biol Phys 12 1986 185
8. J.A. Freeman G. Lieskovsky D.W. Cook Radical retropublic prostatectomy and postoperative adjuvant radiation for pathological stage C (PCN0) prostate cancer from 1976 to 1989: Intermediate findings J Urol 149 1993 1029
9. R.P. Gibbons B.S. Cole R.G. Richardson Adjuvant radiotherapy following radical prostatectomy: Results and complications J Urol 135 1986 65
10. A.W. Partin J. Yoo B.H. Carter The use of prostate specific antigen, clinical stage, and Gleason score to predict athologic stage in men with prostate cancer J Urol 150 1993 110
11. M.V. Pilepich R. Caplan R.W. Byhardt Phase III trial of adjuvant androgen suppression using goserelin in patients with carcinoma of the prostate treated with definitive radiotherapy (results of RTOG 85-31) [abstract 95] Int J Radiat Oncol Biol Phys 32 1995 188
12. M.V. Pilepich J.M. Krall M. Al-Sarraf Androgen deprivation with radiation compared with radiation therapy alone for locally advanced prostatic carcinoma: A randomized comparative trial of the Radiation Therapy Oncology Group Urology 45 1995 616
13. G. Sufrin D.S. Coffey Flutamide: Mechanisms of action of a new nonsteroidal antiandrogen Invest Urol 13 1976 429